01498nam 2200373Ia 450 991069882650332120090528151655.0(CKB)5470000002397603(OCoLC)355680178(EXLCZ)99547000000239760320090528d2001 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufactureRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2001]i, 30 pages digital, PDF fileTitle from PDF title page (viewed on May 28, 2009)."July 2001".Includes bibliographical references (pages 25-26).Guidance for industry BloodTransfusionGovernment policyUnited StatesBlood productsEvaluationGovernment policyUnited StatesBloodTransfusionGovernment policyBlood productsEvaluationGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698826503321Guidance for industry3434577UNINA